Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc, together with its subsidiaries, develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market. The company is involved in the research, development, and production of kits for detection of immune reactions to food under the FoodPrint brand. It also provides clinical analysis to the general public, clinics, and heal… Read more
Cambridge Nutritional Sciences plc (CNSL) - Net Assets
Latest net assets as of September 2025: GBX11.05 Million GBX
Based on the latest financial reports, Cambridge Nutritional Sciences plc (CNSL) has net assets worth GBX11.05 Million GBX as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX12.69 Million) and total liabilities (GBX1.64 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX11.05 Million |
| % of Total Assets | 87.12% |
| Annual Growth Rate | 21.9% |
| 5-Year Change | -51.21% |
| 10-Year Change | -43.48% |
| Growth Volatility | 1448.92 |
Cambridge Nutritional Sciences plc - Net Assets Trend (2004–2025)
This chart illustrates how Cambridge Nutritional Sciences plc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cambridge Nutritional Sciences plc (2004–2025)
The table below shows the annual net assets of Cambridge Nutritional Sciences plc from 2004 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | GBX11.41 Million | +17.84% |
| 2024-03-31 | GBX9.68 Million | -2.70% |
| 2023-03-31 | GBX9.95 Million | -15.78% |
| 2022-03-31 | GBX11.82 Million | -49.47% |
| 2021-03-31 | GBX23.38 Million | +71.84% |
| 2020-03-31 | GBX13.61 Million | -25.19% |
| 2019-03-31 | GBX18.19 Million | +6.24% |
| 2018-03-31 | GBX17.12 Million | -20.21% |
| 2017-03-31 | GBX21.46 Million | +6.29% |
| 2016-03-31 | GBX20.19 Million | +7.30% |
| 2015-03-31 | GBX18.81 Million | +1.92% |
| 2014-03-31 | GBX18.46 Million | +32.20% |
| 2013-03-31 | GBX13.96 Million | +4.79% |
| 2012-03-31 | GBX13.32 Million | +2.77% |
| 2011-03-31 | GBX12.96 Million | +129.47% |
| 2010-03-31 | GBX5.65 Million | +29.44% |
| 2009-03-31 | GBX4.37 Million | +26.16% |
| 2008-03-31 | GBX3.46 Million | +6652.01% |
| 2007-03-31 | GBX51.24K | -58.00% |
| 2005-12-31 | GBX122.00K | -41.06% |
| 2004-12-31 | GBX207.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cambridge Nutritional Sciences plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2376000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX10.26 Million | 89.89% |
| Other Comprehensive Income | GBX-85.00K | -0.75% |
| Other Components | GBX25.07 Million | 219.76% |
| Total Equity | GBX11.41 Million | 100.00% |
Cambridge Nutritional Sciences plc Competitors by Market Cap
The table below lists competitors of Cambridge Nutritional Sciences plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Scottish American Investment Co
LSE:SAIN
|
$579.86 |
|
Energy Finders Inc
PINK:EGYF
|
$580.80 |
|
GUANGZHOU R&F P-H-
MU:G5HA
|
$582.06 |
|
Vallibel Power Erathna PLC
CM:VPELN0000
|
$582.23 |
|
MetaStat Inc
PINK:MTST
|
$578.52 |
|
FieldPoint Petroleum Corporation
PINK:FPPP
|
$578.51 |
|
People’s Merchant Finance PLC
CM:PMBN0000
|
$577.78 |
|
YOMA STRATEGIC HLDG
BE:O3B
|
$577.71 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cambridge Nutritional Sciences plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 9,682,000 to 11,409,000, a change of 1,727,000 (17.8%).
- Net income of 1,566,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 85,000.
- Other factors increased equity by 246,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX1.57 Million | +13.73% |
| Other Comprehensive Income | GBX-85.00K | -0.75% |
| Other Changes | GBX246.00K | +2.16% |
| Total Change | GBX- | 17.84% |
Book Value vs Market Value Analysis
This analysis compares Cambridge Nutritional Sciences plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 39.68x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 2.61x to 39.68x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | GBX0.73 | GBX1.90 | x |
| 2005-12-31 | GBX0.08 | GBX1.90 | x |
| 2007-03-31 | GBX0.02 | GBX1.90 | x |
| 2008-03-31 | GBX0.31 | GBX1.90 | x |
| 2009-03-31 | GBX0.28 | GBX1.90 | x |
| 2010-03-31 | GBX0.30 | GBX1.90 | x |
| 2011-03-31 | GBX0.33 | GBX1.90 | x |
| 2012-03-31 | GBX0.15 | GBX1.90 | x |
| 2013-03-31 | GBX0.16 | GBX1.90 | x |
| 2014-03-31 | GBX0.17 | GBX1.90 | x |
| 2015-03-31 | GBX0.17 | GBX1.90 | x |
| 2016-03-31 | GBX0.18 | GBX1.90 | x |
| 2017-03-31 | GBX0.19 | GBX1.90 | x |
| 2018-03-31 | GBX0.14 | GBX1.90 | x |
| 2019-03-31 | GBX0.14 | GBX1.90 | x |
| 2020-03-31 | GBX0.10 | GBX1.90 | x |
| 2021-03-31 | GBX0.13 | GBX1.90 | x |
| 2022-03-31 | GBX0.06 | GBX1.90 | x |
| 2023-03-31 | GBX0.04 | GBX1.90 | x |
| 2024-03-31 | GBX0.04 | GBX1.90 | x |
| 2025-03-31 | GBX0.05 | GBX1.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cambridge Nutritional Sciences plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.73%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 18.80%
- • Asset Turnover: 0.60x
- • Equity Multiplier: 1.21x
- Recent ROE (13.73%) is above the historical average (-14.41%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | -35.27% | 0.00% | 0.00x | 1.08x | GBX-93.70K |
| 2005 | -69.67% | 0.00% | 0.00x | 1.25x | GBX-97.20K |
| 2008 | 6.88% | 6.82% | 0.43x | 2.33x | GBX-108.00K |
| 2009 | 5.06% | 4.06% | 0.66x | 1.89x | GBX-215.50K |
| 2010 | 3.31% | 3.02% | 0.68x | 1.62x | GBX-378.00K |
| 2011 | 0.24% | 0.39% | 0.45x | 1.34x | GBX-1.27 Million |
| 2012 | 3.95% | 4.74% | 0.67x | 1.25x | GBX-805.47K |
| 2013 | 4.17% | 5.17% | 0.64x | 1.26x | GBX-813.98K |
| 2014 | 3.75% | 5.98% | 0.53x | 1.19x | GBX-1.15 Million |
| 2015 | 3.93% | 6.11% | 0.53x | 1.20x | GBX-1.14 Million |
| 2016 | 2.83% | 4.49% | 0.54x | 1.18x | GBX-1.45 Million |
| 2017 | 3.32% | 5.01% | 0.55x | 1.20x | GBX-1.43 Million |
| 2018 | -42.46% | -87.28% | 0.36x | 1.34x | GBX-8.98 Million |
| 2019 | 5.36% | 11.13% | 0.37x | 1.29x | GBX-844.81K |
| 2020 | -50.18% | -69.54% | 0.52x | 1.38x | GBX-8.19 Million |
| 2021 | -9.00% | -30.87% | 0.23x | 1.26x | GBX-4.44 Million |
| 2022 | -95.91% | -132.72% | 0.48x | 1.51x | GBX-12.51 Million |
| 2023 | -38.79% | -51.15% | 0.52x | 1.45x | GBX-4.86 Million |
| 2024 | -3.39% | -3.36% | 0.70x | 1.44x | GBX-1.30 Million |
| 2025 | 13.73% | 18.80% | 0.60x | 1.21x | GBX425.10K |
Industry Comparison
This section compares Cambridge Nutritional Sciences plc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $65,286,667
- Average return on equity (ROE) among peers: 13.21%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cambridge Nutritional Sciences plc (CNSL) | GBX11.05 Million | -35.27% | 0.15x | $579.03 |
| Advanced Medical Solutions Group plc (AMS) | $152.44 Million | 13.21% | 0.11x | $57.66K |
| Inspecs Group plc (SPEC) | $31.35 Million | 15.67% | 1.28x | $8.66K |
| Tristel (TSTL) | $12.08 Million | 10.75% | 0.25x | $22.16K |